MANNKIND
LIVE

Serial Number

88753466

Owner

MannKind Corporation

Attorney

Jaclyne D. Wallace

First Use Date

Feb 6, 2020

Filing Date

Jan 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MANNKIND Trademark

Serial Number: 88753466 • Registration: 6278902

MANNKIND is a trademark filed by MannKind Corporation on January 9, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

MannKind Corporation (7 trademarks)

1 Casper Street
Danbury, CT 06810

Entity Type: 03

Trademark Details

Filing Date

January 9, 2020

Registration Date

February 23, 2021

First Use Anywhere

February 6, 2020

First Use in Commerce

February 6, 2020

Published for Opposition

May 5, 2020

Goods & Services

Arranging and conducting conferences, seminars and non-downloadable webinars in the field of health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing podcasts in the field of health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Medical information services, including providing a website in the medical, pharmaceutical and health fields featuring information related to health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and/or drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical care consulting services in the fields of diagnostics, patient treatment and treatment protocols

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 23, 2026 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 3, 2025 ASCK
NOTICE OF SUIT
Jun 14, 2024 NOSU
NOTICE OF SUIT
Jun 14, 2024 NOSU
NOTICE OF SUIT
Jun 14, 2024 NOSU
NOTICE OF SUIT
Jun 14, 2024 NOSU
REGISTERED-PRINCIPAL REGISTER
Feb 23, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 21, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 20, 2021 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 7, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jan 6, 2021 SUPC
SOU EXTENSION 1 GRANTED
Jan 6, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 4, 2021 AITU
USE AMENDMENT FILED
Dec 14, 2020 IUAF
SOU EXTENSION 1 FILED
Dec 14, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 14, 2020 EEXT
TEAS STATEMENT OF USE RECEIVED
Dec 14, 2020 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 19, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2020 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 30, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2020 NONP
ASSIGNED TO LIE
Mar 26, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 20, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 20, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 20, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 20, 2020 CNEA
ASSIGNED TO EXAMINER
Mar 19, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2020 NWOS
NEW APPLICATION ENTERED
Jan 13, 2020 NWAP